Hov et al. found that cerebrospinal fluid (CSF) S100B levels were higher in patients with acute delirium and pathological Alzheimer’s disease biomarker P-tau levels, suggesting susceptibility induced by astrocytic activation and tau pathology [52]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.